Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479697 · ClinicalTrials.gov registry record · NA
HIRREM for Stage 1 Primary Hypertension
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03479697 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants.
The verdict
NCT03479697, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine that effects of an intervention called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), on Stage 1 Primary Hypertension (systolic BP 130-139, and/or diastolic BP 80-89).
Interventions
- DEVICE HIRREM
- OTHER Continued Current Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-08-08 |
| Est. Completion | 2020-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479697
The ClinicalTrials.gov registry entry for NCT03479697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIRREM is the first listed.
NCT03479697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479697 about?
NCT03479697 is a clinical study titled "HIRREM for Stage 1 Primary Hypertension". The purpose of this study is to determine that effects of an intervention called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), on Stage 1 Primary Hypertension (systolic BP 130-139, and/or diastolic BP 80-89).
What is the current status of trial NCT03479697?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-08-08. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT03479697?
The interventions under investigation include: HIRREM (DEVICE), Continued Current Care (OTHER).
Who is sponsoring clinical trial NCT03479697?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.